Why Scientists Are Rethinking ADHD as a Systemic Health Condition

Attention-deficit/hyperactivity disorder (ADHD) has long been viewed primarily through a cognitive lens. It is traditionally understood as a neurodevelopmental condition characterized by challenges with focus, hyperactivity, and impulse control. It is incredibly widespread in the United States, impacting an estimated 15.5 million adults and roughly 7 million children.

However, a rapidly growing body of scientific evidence is forcing medical professionals to zoom out. Researchers are discovering that ADHD rarely travels alone; it is deeply intertwined with a constellation of physical ailments. Individuals diagnosed with ADHD face a disproportionately higher risk of developing seemingly unrelated health issues, including:

• Severe anxiety and disordered eating

• Autoimmune diseases and chronic allergies

• Debilitating migraines

• Long COVID

• Chronic pelvic pain and musculoskeletal disorders

This expanding web of co-occurring conditions raises a fundamental, pressing question: Is there a direct, underlying biological mechanism linking ADHD to physical illness, or are these ailments the cumulative result of a lifetime spent navigating untreated symptoms, poor sleep, chronic stress, and medication side effects? To parse the biological realities from the psychological burdens, we look to the latest clinical studies and insights from leading experts in neuroscience, psychiatry, and immunology.

1. The Intersection of ADHD and Chronic Pain

The physical manifestation of pain in those with ADHD has become a major focal point for researchers. A compelling study published in Scientific Reports evaluated 958 adults dealing with treatment-resistant chronic pain. The findings were stark: participants who reported “extremely severe” physical suffering—consistently tracking at a 9 or 10 on a standard 10-point pain scale—were significantly more likely to display prominent ADHD symptoms compared to peers with lower pain scores. Broadly speaking, ADHD symptoms were roughly twice as prevalent among the chronic pain study group than what is typically observed in the general public.

This statistical link is mirrored in clinical practice. Adults with ADHD routinely report higher frequencies of chronic low-back pain, fibromyalgia, and migraines.

Karen Stewart, a clinical psychologist based in Huntsville, Alabama, who specializes in the treatment of ADHD, suggests that core cognitive traits of the disorder may actively heighten physical suffering. Specifically, Stewart points to two common ADHD characteristics:

1. Impulsivity: The tendency to react quickly and intensely to stimuli.

2. Cognitive Rigidity: Difficulty adapting to new thoughts, transitions, or behavioral shifts.

“Our beliefs about our pain and our reactions can amplify or ameliorate our physical suffering,” Stewart notes. When a person struggles with impulsivity, they may subconsciously fall into “catastrophizing”—instantly jumping to the worst possible conclusions about a sudden flare-up. If cognitive rigidity is also present, the individual cannot easily shake or pivot away from those distressing thoughts, physically locking the body into a heightened state of distress.

Margo Pumar, a psychiatrist specializing in ADHD and reproductive psychiatry in San Francisco, witnesses this psychological feedback loop regularly. Patients experiencing severe somatic symptoms frequently get trapped in a looping internal dialogue, asking themselves: “I can’t have this keep happening. I can’t live this way. What if I always have to live this way?”

This psychological anxiety carries severe neurological consequences. Anticipating the worst-case scenario can trigger a neurological phenomenon known as central sensitization. In this state, the central nervous system becomes hyper-reactive, turning up the volume on sensory signals so that normal tactile pressure or minor discomfort is perceived by the brain as intense, unbearable pain. Research indicates that central sensitization is notably more common in the ADHD population.

2. Neuroinflammation: The Cellular Bridge

Beyond behavioral patterns, scientists are investigating a shared biological culprit: neuroinflammation. This occurs when the delicate tissues of the brain and spinal cord experience a localized immune response. While ADHD is broadly accepted to spring from a complex tapestry of genetic vulnerabilities and environmental factors, neuroinflammation is increasingly recognized as a key player in how the disorder presents.

Dr. Eugene Merzon, an ADHD researcher and Israeli Health Ministry-certified ADHD diagnostician, notes that neuroinflammation can fundamentally disrupt the pathways through which neurons communicate and function. This cellular interference directly manifests as the classic, visible signs of ADHD, such as inattention, memory deficits, and executive dysfunction.

What initiates this inflammatory response in the brain remains a subject of intense study, but its downstream effects are undeniable. Ongoing inflammation appears to create a vicious cycle within the nervous system. Valentin Dragoi, a professor of neuroscience at the Houston Methodist Academic Institute, explains the compounding nature of the condition: “Ongoing inflammation may overstimulate the nervous system, making symptoms like pain, fatigue and memory problems worse over time.”

3. Immune Dysregulation and Autoimmunity

The relationship between ADHD and systemic inflammation extends far past the blood-brain barrier. Clinical data reveals that ADHD frequently co-occurs with disorders rooted in immune dysfunction. Jeffrey Newcorn, the director of the division of ADHD and learning disorders within the department of psychiatry at Mount Sinai in New York, points out a clear correlation between ADHD and conditions like:

• Asthma, eczema, and severe environmental allergies

• Rheumatoid arthritis

• Type 1 diabetes

• Hypothyroidism

To explore this, Dr. Merzon and his research team tracked epidemiological data during the early days of the global pandemic. They discovered that an ADHD diagnosis was heavily associated with a higher risk of contracting a COVID-19 infection initially, a greater risk of experiencing severe illness, and a significantly higher likelihood of developing long COVID.

Crucially, these inflammatory tendencies seem to take root very early in life. Another study co-authored by Merzon revealed that children diagnosed with ADHD exhibited elevated inflammatory biomarkers—including notably high counts of eosinophils (immune cells explicitly tied to allergic and inflammatory responses)—at just one year of age, long before behavioral symptoms are typically diagnosed.

This crossover between neurological symptoms and autoimmune processes is also deeply familiar to rheumatologists specializing in conditions like lupus. People living with systemic lupus erythematosus (SLE) frequently experience a sub-condition known as neuropsychiatric lupus, which causes severe brain fog.

For decades, patients presenting with these cognitive symptoms—such as short-term memory loss, difficulty concentrating, mixing up words, and struggling to finish a thought—were dismissed by clinicians who assumed these were merely emotional reactions to living with a exhausting, chronic illness.

However, Meggan Mackay, a Lupus Research Alliance-funded researcher, rheumatologist, and professor at the Feinstein Institutes for Medical Research, highlights that growing evidence points directly to neuroinflammation as the true physical root of this cognitive fog. The structural brain fog of an autoimmune flair can look almost identical to the executive dysfunction of ADHD.

4. The Functional Toll of Executive Dysfunction

Even when leaving cellular biology aside, the purely practical challenge of managing a chronic medical condition with an ADHD brain cannot be overstated. Dr. Newcorn emphasizes that individuals trying to manage complex health problems alongside ADHD often experience worse clinical outcomes simply because modern healthcare demands an immense amount of executive function.

Executive function refers to the suite of mental skills required to organize, plan, prioritize, manage time, and see tasks through to completion. Because executive dysfunction is a core hallmark of ADHD, routine medical management becomes a daily gauntlet.

Consider what is required to manage a condition like diabetes, lupus, or severe asthma:

• Remembering to take multiple medications at exact times everyday

• Monitoring subtle physical symptoms and logging data

• Scheduling and keeping track of numerous specialist appointments

• Maintaining consistent sleep schedules and balanced dietary habits

When an individual’s executive function is compromised, gaps in care naturally occur, which can lead to preventable medical crises and a worsening of the physical condition.

5. Unified Treatment Approaches

Fortunately, recognizing the overlap between these conditions is paving the way for more integrated treatment models. Because the central nervous system controls both cognitive focus and pain signaling, certain pharmaceutical interventions can target both areas simultaneously.

Clinical research demonstrates that stimulant medications traditionally prescribed to treat ADHD, alongside specific classes of antidepressants, can provide dual benefits. These medications help optimize dopamine and norepinephrine levels, which can improve cognitive focus while simultaneously dulling chronic pain pathways and stabilizing co-occurring mood disorders.

Ultimately, the medical community is just beginning to map the deep pathways connecting the mind and the body. “The human brain is infinitely complex and difficult to understand and study,” admits neuroscience professor Valentin Dragoi.

The overriding consensus among modern specialists is that medical models must stop treating ADHD as an isolated mental condition that begins and ends in the brain. As Dr. Margo Pumar sums it up: “It’s one body. There are no secrets. Your brain knows exactly what’s happening in all the parts of your body.”